Link Details
| ID: | 1871 |
| Title: | St. Jude discovers factors that accelerate resistance to Gleevec targeted therapy in lymphoblastic l - http://www.news-medical.net/?id=29210 |
| Pagerank: | N/A |
| Description: | Results of a study by investigators at St. Jude Childrens Research Hospital provide strong evidence for why the drug imatinib (Gleevec), which has revolutionized the treatment of chronic myelogenous leukemia (CML), is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL). |
| Category: | |
| Link Owner: | |
| Date Added: | August 30, 2007 01:01:00 AM |
| Number Hits: | 0 |